Gene Query: MS4A3

Dataset Description Geneva Score
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 207.21
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 207.21
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 120.71
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 95.32
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 92.29
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 92.29
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 78.08
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 75.29
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 72.35
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 70.8
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 70.8
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 60.74
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 60.74
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 56.29
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 52.33
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 52.33
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 51.8
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 50.65
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 49.03
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 41.84
Pharmacologic inhibition of STAT5 in AML 41.63
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 40.58
Gene expression changes associated with resistance to tagraxofusp (SL-401) 38.91
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 37.59
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 37.08
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 36.85
RNA-seq analysis of AML cells in response to ASLAN003 35.47
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 32.68
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 32.68
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 31.61
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 31.08
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 30.73
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 29.96
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 29.96
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 29.32
In situ CAPTURE of chromatin interactions by biotinylated dCas9 29.32
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 29.11
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 27.62
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 27.28
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 26.47
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 25.46
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 24.15
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 23.07
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 23.0
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 22.99
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 22.99
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 22.35
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 22.2
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 21.66
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 21.66
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 20.52
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 20.36
Transcriptome analysis of SKI knock-out in HL60 cells 20.36
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 19.56
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 18.47
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 18.3
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 17.57
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 17.45
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 17.34
RNA-seq of CD33 KO and control HSPCs 17.3
SRSF2 mutations impair hematopoiesis and alter exon recognition 16.97
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 16.75
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 16.18
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 16.13
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 15.92
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 15.92
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 15.72
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 15.72
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 15.32
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 15.31
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 15.25
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 15.22
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 14.95
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 14.72
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 14.72
Global analysis of enhancer targets: Mosaic-seq 14.65
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 14.17
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 14.17
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 13.8
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 12.88
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 12.53
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 11.72
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 11.6
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 11.16
TAF1 is critical for AE driven leukemogenesis 11.16
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 10.65
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 9.95
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 9.86
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 9.55
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 9.22
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 8.93
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 8.86
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 8.29
MEIS1 regulates hematopoiesis in hPSCs 8.21
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 8.19
A single cell reference map for human blood and tissue T cell activation 8.15
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 8.03
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 8.01
Human cells contain natural double-stranded RNAs with potential regulatory capacity 7.81
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 7.77
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 6.93
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 6.88
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 6.8
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 6.43
RNA expression analysis upon JMJD1C depletion 6.4
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 6.4
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 6.31
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 6.31
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 6.31
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 6.3
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 6.25
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 6.11
Spliceosomal disruption of the non-canonical BAF complex in cancer 6.0
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 6.0
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 5.99
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 5.99
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 5.92
RNA-seq of primary patient AML samples 5.9
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 5.83
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 5.79
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 5.76
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 5.7
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 5.64
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 5.62
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 5.55
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 5.54
Leucegene: ALL sequencing 5.49
Clinker: visualizing fusion genes detected in RNA-seq data 5.29
Transcriptome Profiling of Human Primary Monocytes 5.27
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 5.12
A map of gene expression in neutrophil-like cell lines 5.1
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 4.95
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 4.95
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.82
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 4.5
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 4.5
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 4.29
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 4.29
Impact on erythroid progenitor type on erythroid differntiation 4.21
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 4.2
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.19
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.19
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 4.18
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 4.15
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 4.1
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 4.1
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 4.01
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.94
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 3.89
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 3.8
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 3.75
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 3.75
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.72
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.72
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 3.67
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 3.67
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 3.63
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.63
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 3.43
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 3.29
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.2
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.14
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 3.09
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.97
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 2.96
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 2.92
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 2.85
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 2.82
LncRNA expression profiling of ischemic stroke patients 2.77
Bone marrow derived human B cells [normal proB] 2.53
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.53
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 2.52
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.4
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.38
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 2.38
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 2.36
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 2.33
MicroRNA-125a-5p overexpression in human macrophages 2.31
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 2.3
The pioneer factor CEBPA modulates vitamin D signaling 2.28
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 2.28
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 2.2
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 2.19
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 2.11
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 2.11
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 2.11
U2AF1 mutations alter splice site recognition in hematological malignancies 2.05
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.05
Transcription elongation regulates genome 3D structure 2.05
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 2.0
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.85
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 1.81
Single-Cell Genotyping of Transcriptomes 1.78
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.78
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.77
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 1.73
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.72
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.72
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.71
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.67
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.67
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.6
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 1.59
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.58
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.51
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.51
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 1.42
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 1.39
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 1.31
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.29
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.27
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 1.25
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 1.08
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.08
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 1.05
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 1.04
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 1.04
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 1.03
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 1.0
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.99
Transcriptome-wide response to synthetic chromatin protein PcTF 0.98
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.98
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.98
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 0.94
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.89
Peptidomimetic blockade of MYB in acute myeloid leukemia 0.89
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 0.89
Transcriptome sequencing of K-562 cells 0.89
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 0.88
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.84
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 0.8
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 0.76
Transcription control by the ENL YEATS domain in acute leukemia 0.76
The pause-initiation limit restricts transcription activation in human cells 0.73
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 0.71
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.7
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 0.69
Comprehensive comparative analysis of 5’ end RNA sequencing methods 0.68
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 0.65
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.64
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.62
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 0.6
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.59
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.59
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.58
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.58
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.56
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.56
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.53
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.53
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.52
Targeting MTHFD2 in Acute Myeloid Leukemia 0.51
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.51
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 0.5
Accurate annotation of human protein-coding small open reading frames 0.48
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 0.48
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 0.48
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 0.45
Solid phase chemistry to covalently and reversibly capture thiolated RNA 0.44
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.44
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.43
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.43
Short and Long RNA sequencing of human mature erythrocytes 0.42
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.42
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.41
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.39
Dysregulated immune system networks in war veterans with PTSD 0.39
K562 polyA RNA-Seq 0.39
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.36
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 0.35
Targeted enhancer activation by a subunit of the integrator complex 0.34
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 0.34
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 0.33
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.32
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 0.3
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 0.3
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.29
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 0.28
Leucegene: AML sequencing (part 6) 0.24
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.24
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.24
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.23
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.23
Genome-wide discovery of human splicing branchpoints 0.21
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 0.21
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 0.21
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 0.2
Measure transcript integrity using RNA-seq data 0.19
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 0.19
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.19
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.18
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.18
RNA sequencing of primary human platelets and in vitro cell lines 0.18
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 0.18
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 0.17
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 0.16
Differential gene expression profiles in imatinib-resistant cell lines 0.16
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 0.16
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 0.16
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 0.16
Aging-associated patterns in the expression of human endogenous retroviruses 0.16
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 0.16
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 0.16
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.15
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.15
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.15
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.13
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.12
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.12
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.12
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.11
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 0.11
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.11
Transcriptomes in healthy and CHB fetal hearts 0.11
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.11
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 0.11
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 0.11
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.1
Tpl-2 small molecule project 0.1
Tpl-2 and MEK small molecule inhibitors 0.1
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.1
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.1
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.09
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 0.09
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 0.09
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 0.09
Intron retention induced by microsatellite expansions as a disease biomarker. 0.09
Hepatosplenic T cell lymphoma 0.09
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.09
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 0.09
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 0.09
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.09
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.08
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.08
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.08
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.08
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.08
Microglia innatly develop within cerebral organoids 0.08
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 0.08
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.08
Genome-wide discovery of human splicing branchpoints [RNAse] 0.08
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 0.08
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 0.08
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 0.08
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 0.08
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.07
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 0.07
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.07
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 0.07
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 0.07
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.06
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 0.06
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.06
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 0.06
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 0.06
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 0.06
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 0.06
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 0.06
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 0.06
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.06
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 0.06
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.05
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.05
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 0.05
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 0.05
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 0.05
RNA-Seq and expression data from human adipose tissue 0.05
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.05
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.05
Reassessment of Exosome Composition 0.04
circRNA-sequencing 0.04
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.04
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.04
Transcriptome analysis of CNS leukemia 0.04
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 0.04
RNA sequencing of T-ALL (COG study) 0.04
Analyses of T-ALL (COG study) 0.04
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.04
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 0.04
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.04
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.03
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 0.03
TT-Seq captures the human transient transcriptome 0.03
Transcriptome of diurnal human blood neutrophils 0.03
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.03
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 0.03
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 0.03
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.03
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 0.03
Transcriptome of Stabilin-1 siRNA transfected human monocytes 0.03
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 0.03
Specific molecular signatures underlie response to decitabine in CMML 0.02
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.02
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.02
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.02
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 0.02
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 0.02
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 0.02
Transcriptomes of human monocytes after ex vivo exposure to uric acid 0.02
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.02
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.02
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.02
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.02
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.02
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.02
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.02
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 0.02
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.02
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 0.02
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.02
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 0.02
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 0.02
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 0.02
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.02
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 0.02
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 0.02
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.02
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 0.02
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 0.02
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.02
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 0.02
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 0.02
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.02
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 0.02
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 0.02
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 0.02
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 0.01
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 0.01
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 0.01
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.01
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 0.01
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 0.01
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.01
Expression data from miR340 overexpressing human A549 cells 0.01
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.01
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.01
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.01
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.01
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.01
quanTIseq: quantifying immune contexture of human tumors 0.01
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.01
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.01
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.01
Characterization of the Merkel cell carcinoma miRNome 0.01
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.01
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.01
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.01
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.01
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 0.01
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 0.01
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.01
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.01
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 0.01
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.01
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.01
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.01
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 0.01
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.01
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 0.01
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.01
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.01
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.01
The expression profiles of GBC liver metastasis 0.01
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.01
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 0.01
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.01
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 0.01
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 0.01
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 0.01
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.0
The transcriptome of Kawasaki Disease arteritis 0.0
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.0
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.0
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.0
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.0
Transcriptional profile in human S. haematobium infection 0.0
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.0
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.0
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 0.0
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 0.0
Total RNA-Seq data from leukemic patients with complex structural variants 0.0
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.0
Expression analysis of the TAF1 syndrome 0.0
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.0
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.0
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.0
siRNA-mediated knockdown 0.0
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 0.0
Defective structural RNA processing in relapsing-remitting multiple sclerosis 0.0
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.0
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.0
Transcriptomic profiling of human peripheral blood-derived mast cells 0.0
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.0
Anti-inflammatory effect of indoleacrylic acid (IA) 0.0
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.0
RNA-seq data 0.0
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.0
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 0.0
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.0
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation